Search

Search Constraints

You searched for: Author/Creator Boualit, Medina

Search Results

1. Adalimumab dose escalation is effective and well tolerated in Crohn's disease patients with secondary loss of response to adalimumab. Issue 2 (February 2017)

2. Patients with Crohn's Disease with High Body Mass Index Present More Frequent and Rapid Loss of Response to Infliximab. Issue 10 (October 2017)

3. Patients' real-world experience with inflammatory bowel disease: A cross-sectional survey in tertiary care centres from the GETAID group. Issue 4 (April 2021)

4. Prevalence of anti-TNF contraindications in Crohn's disease: A cross-sectional survey from the GETAID. Issue 10 (October 2022)

5. Safety of ustekinumab or vedolizumab in pregnant inflammatory bowel disease patients: a multicentre cohort study. Issue 4 (7th December 2020)

6. Safety of ustekinumab or vedolizumab in pregnant inflammatory bowel disease patients: a multicentre cohort study. Issue 4 (7th December 2020)

7. The IBD-disk Is a Reliable Tool to Assess the Daily-life Burden of Patients with Inflammatory Bowel Disease. (27th November 2020)